Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 9

Results: 38

Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts.

Published in:

2003

By:

Lunghi, P.;
Tabilio, A.;
Dall&primeAgilo, P.P.;
Ridolo, E.;
Carlo-Stela, C.;
Pelicci, P.G.;
Bonati, A.;
Dall'Aglio, P P;
Carlo-Stella, C

Publication type:

journal article

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1687, doi. 10.1038/sj.leu.2403033

By:

Paschka, P.;
Müller, M.C.;
Merx, K.;
Kreil, S.;
Schoch, C.;
Lahaye, T.;
Weisser, A.;
Petzold, A.;
Künig, H.;
Berger, U.;
Gschaidmeier, H.;
Hehlmann, R.;
Hochhaus, A.

Publication type:

Article

No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1827, doi. 10.1038/sj.leu.2403035

By:

Hast, R.;
Hellstr&oumlm-Lindberg, E.;
Ohm, L.;
Björkholm, M.;
Celsing, F.;
Dahl, I.-M.;
Dybedal, I.;
Gahrton, G.;
Lindberg, G.;
Lerner, R.;
Linder, O.;
Löfvenberg, E.;
Nilsson-Ehle, H.;
Paul, C.;
Samuelsson, J.;
Tangen, J.-M.;
Tidefelt, U.;
Turresson, I.;
Wahlin, A.;
Wallvik, J.

Publication type:

Article

Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1858, doi. 10.1038/sj.leu.2403036

By:

B.-W. Gu, M.;
Q. Wang;
J.-M. Wang, M.;
Y.-Q. Xue, M.;
J. Fang;
K. F. Wong, M.;
B. Chen, M.;
Z.-Z. Shi, M.;
J.-Y. Shi, M.;
X.-T. Bai, M.;
D.-H. Wu, M.;
Z. Chen;
S.-J. Chen, M.

Publication type:

Article

Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1901, doi. 10.1038/sj.leu.2403037

By:

Mozziconacci, M.J.;
Caillères, S.;
Maurice, C.;
Vey, N.;
Sainty, D.;
Blaise, D.;
Lafage-Pochitaloff, M.

Publication type:

Article

Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1903, doi. 10.1038/sj.leu.2403046

By:

Aoki, E.;
Ohashi, H.;
Uchida, T.;
Murate, T.;
Saito, H.;
Kinoshita, T.

Publication type:

Article

Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon a.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1820, doi. 10.1038/sj.leu.2403042

By:

Berger, U.;
Engelich, G.;
Maywald, O.;
Pfirrmann, M.;
Hochhaus, A.;
Reiter, A.;
Metzgeroth, G.;
Gnad, U.;
Hasford, J.;
Heinze, B.;
Heimpel, H.;
Hossfeld, D.K.;
Kolb, H.-J.;
Löffler, H.;
Pralle, H.;
Queisser, W.;
Hehlmann, R.

Publication type:

Article

Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1695, doi. 10.1038/sj.leu.2403040

By:

Miething, C.;
Mugler, C.;
Grundler, R.;
Hoepfl, J.;
Bai, R.-Y.;
Peschel, C.;
Duyster, J.

Publication type:

Article

A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.

Published in:

2003

By:

Martelli, A.M.;
Tazzari, P.L.;
Tabellini, G.;
Bortul, R.;
Billi, A.M.;
Manzoli, L.;
Ruggeri, A.;
Conte, R.;
Cocco, L.

Publication type:

journal article

Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?

Published in:

2003

By:

Lübbert, M.;
Lübbert, M

Publication type:

journal article

Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1834, doi. 10.1038/sj.leu.2403038

By:

van der Velden, V.H.J.;
Szczepanski, T.;
Wijkhuijs, J.M.;
Hart, P.G.;
Hoogeveen, P.G.;
Hop, W.C.J.;
van Wering, E.R.;
van Dongen, J.J.M.

Publication type:

Article

Environmental factors contributing to the development of childhood leukemia in children with Down's syndrome.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1905, doi. 10.1038/sj.leu.2403047

By:

Mejía-Aranguré, J.M.;
Fajardo-Gutiérrez, A.;
Flores-Aguilar, H.;
Martínez-García, M.C.;
Salamanca-Gómez, F.;
Palma-Padilla, V.;
Paredes-Aguilera, R.;
Bernáldez-Ríos, R.;
Ortiz-Fernández, A.;
Martínez-Avalos, A.;
Gorodezky, C.

Publication type:

Article

Dendritic cells: interfaces with immunobiology and medicine. A report from the Keystone Symposia Meeting held in Keystone, 3-8 March 2003.

Published in:

2003

By:

Mohty, M.;
Gaugler, B.

Publication type:

research

Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.

Published in:

2003

By:

Grigg, A.;
Kimber, R.;
Szer, J.

Publication type:

Case Study

Molecular identification of CBFß-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses - a rare occurrence.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1907, doi. 10.1038/sj.leu.2403056

By:

Ravandi, F.;
Kadkol, S.S.;
Ridgeway, J.;
Bruno, A.;
Dodge, C.;
Lindgren, V.

Publication type:

Article

Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1765, doi. 10.1038/sj.leu.2403052

By:

Shelton, J.G.;
Moye, P.W.;
Steelman, L.S.;
Blalock, W.L.;
Lee, J.T.;
Franklin, R.A.;
McMahon, M.;
McCurbey, J.A.

Publication type:

Article

Small-molecule inhibitors of signal transduction pathways in leukemia therapeutics: how to assess selectivity for malignant signals.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1759, doi. 10.1038/sj.leu.2403053

By:

White, M.K.

Publication type:

Article

Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1813, doi. 10.1038/sj.leu.2403054

By:

Christiansen, D.H.;
Anderson, M.K.;
Pedersen-Bjergaard, J.

Publication type:

Article

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1865, doi. 10.1038/sj.leu.2403055

By:

Kumar, S.;
Chen, M.G.;
Gastineau, D.A.;
Gertz, M.A.;
Inwards, D.J.;
Lacy, M.Q.;
Tefferi, A.;
Litzow, M.R.

Publication type:

Article

Reply to A Grigg et al.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1918, doi. 10.1038/sj.leu.2403051

By:

Tedeschi, A.;
Montillo, M.;
Morra, E.

Publication type:

Article

High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1880, doi. 10.1038/sj.leu.2403057

By:

Islam, T.C.;
Asplund, A.C.;
Lindvall, J.M.;
Nygren, L.;
Liden, J.;
Kimby, E.;
Christensson, B.;
Smith, C.I.E.;
Sander, B.

Publication type:

Article

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1914, doi. 10.1038/sj.leu.2403058

By:

Damaj, G.;
Lefrère, F.;
Delarue, R.;
Varet, B.;
Furman, R.;
Hermine, O.

Publication type:

Article

Generation of immunostimulatory dendritic cells from the malignant clone in patients with juvenile myelomonocytic leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1910, doi. 10.1038/sj.leu.2403059

By:

Nabarro, S.;
Thrasher, A.J.;
Kempski, H.;
Amrolia, P.;
Anderson, J.

Publication type:

Article

Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.

Published in:

2003

By:

Gutierrez, M.I.;
Siraj, A.K.;
Bhargava, M.;
Ozbek, U.;
Banavali, S.;
Chaudhary, M.A.;
El Solh, H.;
Bhatia, K.

Publication type:

journal article

t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1851, doi. 10.1038/sj.leu.2403061

By:

Berger, R.;
Dastugue, N.;
Busson, M.;
van den Akker, J.;
Pérot, C.;
Ballerini, P.;
Hagemeijer, A.;
Michaux, L.;
Charrin, C.;
Pages, M.P.;
Mugneret, F.;
Andrieux, J.;
Talmant, P.;
Hélias, C.;
Mauvieux, L.;
Lafage-Pochitaloff, M.;
Mozziconacci, M-J;
Cornillet-Lefebvre, P.;
Radford, I.;
Asnafi, V.

Publication type:

Article

Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1700, doi. 10.1038/sj.leu.2403062

By:

Scheuring, U.J.;
Pfeifer, H.;
Wassmann, B.;
Brück, P.;
Gehrke, B.;
Petershofen, E.K.;
Gschaidmeier, H.;
Hoelzer, D.;
Ottmann, O.G.

Publication type:

Article

Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis.

Published in:

2003

By:

Liesveld, J.L.;
Lancet, J.E.;
Rosell, K.E.;
Menon, A.;
Lu, C.;
McNair II, C.;
Abboud, C.N.;
Rosenblatt, J.D.;
McNair, C

Publication type:

journal article

Association of acute leukemia and autoimmune polyendocrine syndrome in two kindreds.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1912, doi. 10.1038/sj.leu.2403064

By:

Willems, E.;
Valdes-Socin, H.;
Betea, D.;
Beckers, A.;
Beguin, Y.

Publication type:

Article

Retinoid target genes in acute promyelocytic leukemia.

Published in:

2003

By:

Pitha-Rowe, I.;
Petty, W.J.;
Kitareewan, S.;
Dmitrovsky, E.

Publication type:

journal article

AML with t(8;21) and trisomy 4: possible involvement of c-kit?

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1915, doi. 10.1038/sj.leu.2403066

By:

Langabeer, S.E.;
Beghini, A.;
Larizza, L.

Publication type:

Article

FLT3: ITDoes matter in leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1738, doi. 10.1038/sj.leu.2403099

By:

Levis, M.;
Small, D.

Publication type:

Article

Reply to SE Langabeer et al.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1915, doi. 10.1038/sj.leu.2403067

By:

v., F. Lorenzo;
Nishii, K.;
Usui, E.;
Katayama, N.;
Shiku, H.

Publication type:

Article

Tolerance induction by costimulator blockade in 100?cGy treated hosts with varying degrees of genetic disparity.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1871, doi. 10.1038/sj.leu.2403070

By:

Abedi, M.;
Greer, D.;
Lambert, J.F.;
Colvin, G.A.;
Dooner, M.S.;
McAuliffe, C.I.;
Demers, D.;
Moore, B.E.;
Queensberry, P.J.

Publication type:

Article

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1722, doi. 10.1038/sj.leu.2403072

By:

Bacigalupo, A.

Publication type:

Article

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1707, doi. 10.1038/sj.leu.2403068

By:

Olavarria, E.;
Ottmann, O.G.;
Deininger, M.;
Clark, R.E.;
Bandini, G.;
Byrne, J.;
Lipton, J.;
Vitek, A.;
Michallet, M.;
Siegert, W.;
Ullman, A.;
Wassmann, B.;
Niederwieser, D.;
Fischer, T.

Publication type:

Article

Transforming growth factor-ß signaling in normal and malignant hematopoiesis.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1731, doi. 10.1038/sj.leu.2403069

By:

Kim, S.-J.;
Letterio, J.

Publication type:

Article

Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1713, doi. 10.1038/sj.leu.2403071

By:

Dewar, A.L.;
Domaschenz, R.M.;
Doherty, K.V.;
Hughes, T.P.;
Lyons, A.B.

Publication type:

Article

Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR.

Published in:

Leukemia (08876924), 2003, v. 17, n. 9, p. 1891, doi. 10.1038/sj.leu.2403073

By:

Qiu, J.;
Gunaratne, P.;
Peterson, L.E.;
Khurana, D.;
Walsham, N.;
Loulseged, H.;
Karni, R.J.;
Roussel, E.;
Gibbs, R.A.;
Margolin, J.F.;
Gingras, M.C.

Publication type:

Article

Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 9

Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts.

Molecular monitoring of response to imatinib (Glivec<sup>®</sup>) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.

No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.

Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.

Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.

Expression levels of DNA methyltransferase genes do not correlate with p15<sup>INK4B</sup> gene methylation in myelodysplastic syndromes.

Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon a.

Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo.

A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.

Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?

Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.

Environmental factors contributing to the development of childhood leukemia in children with Down's syndrome.

Dendritic cells: interfaces with immunobiology and medicine. A report from the Keystone Symposia Meeting held in Keystone, 3-8 March 2003.

Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.

Molecular identification of CBFß-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses - a rare occurrence.

Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.

Small-molecule inhibitors of signal transduction pathways in leukemia therapeutics: how to assess selectivity for malignant signals.

Methylation of p15<sup>INK4B</sup> is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.

Reply to A Grigg et al.

High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

Generation of immunostimulatory dendritic cells from the malignant clone in patients with juvenile myelomonocytic leukemia.

Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.

t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).

Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph<sup>+</sup>ALL) during imatinib treatment.

Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis.

Association of acute leukemia and autoimmune polyendocrine syndrome in two kindreds.

Retinoid target genes in acute promyelocytic leukemia.

AML with t(8;21) and trisomy 4: possible involvement of c-kit?

FLT3: ITDoes matter in leukemia.

Reply to SE Langabeer et al.

Tolerance induction by costimulator blockade in 100?cGy treated hosts with varying degrees of genetic disparity.

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

Transforming growth factor-ß signaling in normal and malignant hematopoiesis.

Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.

Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR.